Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.8M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
33.2M
-
Shares change
-
-4.94M
-
Total reported value, excl. options
-
$299M
-
Value change
-
-$90.4M
-
Put/Call ratio
-
1.28
-
Number of buys
-
84
-
Number of sells
-
-100
-
Price
-
$8.99
Significant Holders of RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) as of Q3 2025
203 filings reported holding RXST - RxSight, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
RxSight, Inc. - Common Stock, par value $0.001 per share (RXST) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.2M shares
of 40.8M outstanding shares and own 81.5% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.7M shares), MILLENNIUM MANAGEMENT LLC (2.19M shares), VANGUARD GROUP INC (2.15M shares), D. E. Shaw & Co., Inc. (1.83M shares), Artisan Partners Limited Partnership (1.75M shares), No Street GP LP (1.63M shares), CITADEL ADVISORS LLC (1.29M shares), DEUTSCHE BANK AG\ (968K shares), BNP PARIBAS FINANCIAL MARKETS (904K shares), and MORGAN STANLEY (845K shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.